142
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Carbapenems versus Cephalosporin or Piperacillin-Tazobactam as Perioperative Antibiotic Prophylaxis in Liver Transplant Recipients with Model for End-Stage Liver Disease Scores of ≥30: A Retrospective Study in a Chinese Population

, ORCID Icon, , , , & show all
Pages 4487-4494 | Published online: 12 Aug 2022

References

  • Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after liver transplantation–part I. Liver Transplant. 2005;11(12):1452–1459.
  • Kawecki D, Chmura A, Pacholczyk M, et al. Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit. 2009;15(12):Cr628–637.
  • Paya CV, Hermans PE. Bacterial infections after liver transplantation. Eur J Clin Microbiol Infect Dis. 1989;8(6):499–504.
  • Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol. 2011;3(4):83–92.
  • Bartlett ST. Pancreatic transplantation after thirty years: still room for improvement. J Am Coll Surg. 1996;183(4):408–410.
  • Novick AC. The value of intraoperative antibiotics in preventing renal transplant wound infections. J Urol. 1981;125(2):151–152.
  • Ramos E, Karmi S, Alongi SV, Dagher FJ. Infectious complications in renal transplant recipients. South Med J. 1980;73(6):751–754.
  • Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195–283.
  • Santoro-Lopes G, de Gouvêa EF. Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge. World J Gastroenterol. 2014;20(20):6201–6210.
  • Herati RS, Blumberg EA. Losing ground: multidrug-resistant bacteria in solid-organ transplantation. Curr Opin Infect Dis. 2012;25(4):445–449.
  • van Duin D, van Delden C. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):31–41.
  • Centers for Disease Control and Prevention. FAQs about choosing and implementing a CRE definition. Available from: https://www.cdc.gov/hai/organisms/cre/technical-info.html#Definition. Accessed August 9, 2022.
  • CDC/NHSN. CDC/NHSN surveillance definitions for specific types of infections. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Accessed August 9, 2022.
  • Almeida RA, Hasimoto CN, Kim A, Hasimoto EN, El Dib R. Antibiotic prophylaxis for surgical site infection in people undergoing liver transplantation. Cochrane Database Syst Rev. 2015;2015(12):Cd010164.
  • Kim SI. Bacterial infection after liver transplantation. World J Gastroenterol. 2014;20(20):6211–6220.
  • García Prado ME, Matia EC, Ciuro FP, et al. Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis. Transplantation. 2008;85(12):1849–1854.
  • Asensio A, Ramos A, Cuervas-Mons V, et al. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant. Liver Transplant. 2008;14(6):799–805.
  • Berry PS, Rosenberger LH, Guidry CA, Agarwal A, Pelletier S, Sawyer RG. Intraoperative versus extended antibiotic prophylaxis in liver transplant surgery: a randomized controlled pilot trial. Liver Transplant. 2019;25(7):1043–1053.
  • Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281.
  • Anesi JA, Blumberg EA, Abbo LM. Perioperative antibiotic prophylaxis to prevent surgical site infections in solid organ transplantation. Transplantation. 2018;102(1):21–34.
  • Giannella M, Bartoletti M, Morelli MC, et al. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization. Am J Transplant. 2015;15(6):1708–1715.
  • Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58(9):1274–1283.
  • Pereira MR, Scully BF, Pouch SM, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transplant. 2015;21(12):1511–1519.
  • Chen Y, Wang WL, Zhang W, et al. Risk factors and outcomes of carbapenem-resistant Enterobacteriaceae infection after liver transplantation: a retrospective study in a Chinese population. Infect Drug Resist. 2020;13:4039–4045.
  • Kalpoe JS, Sonnenberg E, Factor SH, et al. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transplant. 2012;18(4):468–474.